Hi, we have coronavirus testing kits from China
What is Home-Check Menopause test? This is a home-use test kit to measure Follicle Stimulating Hormone (FSH) in your urine. This may help indicate if you are in menopause or perimenopause. Why should you do this Home-Check Menopause test? You should use this test if you want to know if your symptoms, such as irregular periods, hot flushes, vaginal dryness, or sleep problems are due to high levels of FSH which may be part of menopause. While many women may have little or no trouble when going through the stages of menopause, others may have moderate to severe discomfort and may want treatment to alleviate their symptoms. This test may help you be better informed about your current condition when you see your doctor. Key Features * Over 99% accurate* * Fast results – within minutes * Convenient * AUST L 174939 - approved by the TGA, European authorities and Indian FDA * Detects FSH levels higher than 25mlU/ml. Pack Contains: 1 In-stream Home-Check Menopause Menopause Test 1 Instruction Leaflet. Precautions: For external use only Always read the label Use only as directed. *In laboratory and consumer clinical studies.
Can supply Korean COVID Test kits. MOQ 10,000 test kits.
* Manufactured by Guangzhou Wondfu Biotech Co., Ltd, the leading and publicly traded corporation authorized to manufacture and distribute COVID anti-body rapid tests * Diagnosis for COVID-19 with instant result in 15 minutes * Detection for both IgG and IgM antibody
Novel Coronavirus (COVID-19) Test Kit (5mins test)
The novel Antigen Rapid Test swab is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in Nasopharyngeal swab and Oropharyngeal swab using the rapid method with a reading result in 10-15 minutes.
VTM's - Virus Collection & Preservation System Used for universal virus collection and storage in a short time. Class 1
Livzon Rapid Test for SARS-CoV-2 Antigen (Lateral Flow) Livzon Rapid Test for SARS-CoV-2 Antigen (Lateral Flow) is used for in vitro qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal swabs, oropharyngeal swabs and nasal swabs from individuals who are suspected of SARS-CoV-2 by their healthcare provider within the first seven days of symptom onset.
